Cedar Hill Associates’s Colgate-Palmolive CL Stock Holding History

Cedar Hill Associates’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,693	Closed	-$203K	–	145
2017 Q4	$203K	Buy	+2,693	New	+$197K	0.04%	143

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cedar Hill Associates's CL Position: Q1 2018 in Review

Cedar Hill Associates sold out of Colgate-Palmolive (CL) in Q1 2018, closing a stake of 2,693 shares — an estimated $203K sold.

Cedar Hill Associates first reported a position in CL in Q4 2017 and held it in 1 quarter. The position peaked at $203K in Q4 2017. 1,438 funds tracked by Wall St. Rank hold CL as of Q1 2018.

Cedar Hill Associates reported no remaining Colgate-Palmolive position as of Q1 2018 after selling out during the quarter.
Cedar Hill Associates sold 2,693 Colgate-Palmolive shares in Q1 2018, an estimated $203K.
Cedar Hill Associates first reported a position in Colgate-Palmolive in Q4 2017 and held it in 1 quarter.
Cedar Hill Associates's Colgate-Palmolive position peaked at $203K in Q4 2017.
1,438 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2018.

Based on Cedar Hill Associates's 13F filing for Q1 2018, filed 1 May 2018.